Transgenomic Inc (TBIO) 4.3000 $TBIO Dr. Michael A.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Transgenomic Inc (TBIO) 4.3000 $TBIO

Dr. Michael A. Luther Joins Transgenomic's Board of Directors
Business Wire - Wed Mar 19, 6:00AM CDT
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced the appointment of Michael A. Luther, Ph.D., to its Board of Directors. Dr. Luther will also become a member of the Board's audit committee. His appointment became effective March 13, 2014.

Transgenomic Reports Fourth Quarter and Fiscal Year 2013 Financial Results
Business Wire - Wed Mar 12, 3:10PM CDT
Transgenomic, Inc. (OTC/BB: TBIO) today reported financial results for the fourth quarter and year ended December 31, 2013, and provided a business update.

Reminder: Transgenomic to Hold Fourth Quarter Financial Results Conference Call Today
Business Wire - Wed Mar 12, 7:44AM CDT
Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:

Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 12, 2014
Business Wire - Thu Mar 06, 10:51AM CST
Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:

Transgenomic Announces $7 Million Convertible Preferred Stock Financing
Business Wire - Thu Mar 06, 6:30AM CST
Transgenomic, Inc. (OTCBB:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that it has entered into an agreement with affiliates of Third Security, LLC ("Third Security"), a leading life sciences investment firm founded by R.J. Kirk, to sell to them 1,443,297 million Series B convertible preferred shares at a price of $4.85 per share for gross proceeds of $7.0 million.

Barrick Announces Agreement to Divest its Minority Interest in Marigold in Nevada
Marketwire - Tue Feb 04, 12:11AM CST
All amounts expressed in US dollars unless otherwise indicated.

Transgenomic Announces Issuance of Key U.S. Patent for ICE COLD-PCR
Business Wire - Tue Jan 21, 6:00AM CST
Transgenomic, Inc. (OTCBB:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a new patent related to its licensed ICE COLD-PCR technology. The patent, titled "Full cold-PCR enrichment with reference blocking sequence", was assigned U.S. Patent No. 8,623,603 and is set to expire in 2031.

Horizon Discovery and Transgenomic Announce Collaboration for Validation Control and Development of Genetic Diagnostic Tests
Business Wire - Thu Jan 16, 6:19AM CST
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls. The collaboration will enable Transgenomic to transition from the use of plasmid-derived controls, to Horizon's Quantitative Molecular Reference Standards for all of its existing assays, and for any new assays developed in future.

Transgenomic Files Application for The NASDAQ Capital Market Listing and Board Approves Reverse Stock Split Ratio
Business Wire - Thu Jan 16, 6:00AM CST
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that it has filed an application for listing its common shares on The NASDAQ Capital Market.

2013 Report on the International Molecular Diagnostics Markets
M2 - Mon Jan 13, 6:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/82rrrq/molecular) has announced the addition of the "Molecular Diagnostics Markets" report to their offering. This report helps readers by Identifying viable technology drivers through a comprehensive look at platform technologies for molecular diagnostics, including probe-based nucleic acid assays, microarrays and sequencing. Readers will also obtain a complete understanding of the chief molecular diagnostics tests--i.e., predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic--from their basic principles to their applications; The research will help people discovering feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas and by focusing on expanding markets, such as communicable diseases, cardiology and oncology; By focusing on global industry development through an in-depth analysis of the major world markets for molecular diagnostics, including growth forecasts, readers will gain a thorough understanding of the molecular diagnostic market. Key Topics Covered: 1. Overview 2. Introduction to Molecular Diagnostics and PCR Technology 3. Business Landscape for the Molecular Diagnostics Market Sectors 4. Overview of Clinical Molecular Diagnostic Platforms on the Market 5. Molecular Diagnostic Testing and Infectious Diseases 6. Cancer Detection Using Molecular Diagnostics 7. Genetics Testing in Molecular Diagnostics 8. Molecular Diagnostics Uses in Industrial Testing and Food Diagnostics 9. Bioterrorism and Molecular Diagnostics 10. Regulatory Requirements 11. Reimbursement Issues and Billing Landscape for Molecular Diagnostics Testing 12. Company Profiles Companies Mentioned: - Abbott Laboratories - Beckman Coulter - Cancer Genetics, Inc - DiagnoCure, Inc - Exiqon - Genera Biosystems - Hologic - Illumina - Luminex - Myriad Genetics, Inc - Nanosphere - Orion Genomics - PerkinElmer Genetics - Progenika - QIAGEN NV - Roche Diagnostics - Rosetta Genomics Ltd - Seegene - Sequenom, Inc - Siemens Healthcare Diagnostics (Siemens) - Spartan Bioscience - Thorne Diagnostics - Transgenomic - TrimGen - Trovagene, Inc - Veredus Laboratories - Veridex For more information visit http://www.researchandmarkets.com/research/82rrrq/molecular

Faruqi & Faruqi, LLP Launches An Investigation Against Transgenomic Inc. (TBIO) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
Business Wire - Fri Dec 27, 1:42PM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Transgenomic Inc. ("Transgenomic" or the "Company") (OTC: TBIO) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders' approval for amendments to the Company's 2006 Equity Incentive Plan

Transgenomic Appoints Stephen R. Miller as Senior Vice President and General Manager of Patient Testing Business Unit
Business Wire - Mon Nov 18, 6:30AM CST
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that Stephen R. Miller has been named Senior Vice President and General Manager, Patient Testing.

Transgenomic Down 18.5%, Shares Slide into the Red (TBIO)
Comtex SmarTrend(R) - Fri Nov 08, 11:44AM CST
Transgenomic (NASDAQ:TBIO) is one of today's worst performing penny stocks, down 18.5% to $0.44 on 1.3x average daily volume. Thus far today, Transgenomic has traded 324,000 shares, vs. average volume of 255,000 shares per day. The stock has underperformed the Dow (-20.0% to the Dow's 0.6%) and underperformed the S&P 500 (-20.0% to the S&P's 0.9%) during today's trading.

Transgenomic Reports Third Quarter 2013 Financial Results
Business Wire - Wed Nov 06, 3:05PM CST
Transgenomic, Inc. (OTC/BB:TBIO) today reported financial results for the three and nine months ended September 30, 2013, and provided a business update.

Reminder: Transgenomic to Hold Third Quarter Financial Results Conference Call Today
Business Wire - Wed Nov 06, 8:00AM CST
Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:

Transgenomic Inc partners with PerkinElmer Inc for oncology diagnostic test portfolio
M2 - Mon Nov 04, 7:24AM CST
Biotechnology company Transgenomic Inc (OTC Markets:TBIO) reported on Friday the launch of a partnership to market and distribute its oncology diagnostic test portfolio of products in territories outside the US.

Stock Reports on PGLO, HPTO and TBIO
ACCESSWIRE - Mon Nov 04, 12:04AM CST
Pan Global Corp (OTC: PGLO), Hopto Inc (OTC:HPTO) and Transgenomic Inc (OTC:TBIO) have been added to our watch list.

Transgenomic Signs Commercialization Collaboration with PerkinElmer for Oncology Diagnostic Test Portfolio
Business Wire - Fri Nov 01, 7:00AM CDT
Transgenomic, Inc. (OTCBB:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that it has entered into a collaboration agreement with PerkinElmer, Inc.(NYSE KI) a global leader focused on improving the health and safety of people and the environment, to market and distribute Transgenomic's oncology diagnostic test portfolio of products in territories outside the United States.

Transgenomic to Hold Third Quarter Financial Results Conference Call on November 6, 2013
Business Wire - Wed Oct 30, 8:25AM CDT
Transgenomic, Inc. (OTCBB: TBIO) today announced the following Webcast:

Transgenomic Announces Presentation of MD Anderson ICE COLD-PCR Clinical Data at 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Business Wire - Wed Oct 23, 8:00AM CDT
Transgenomic, Inc. (OTCBB: TBIO) today announced the results of a research collaboration with the MD Anderson Cancer Center employing the Company's ICE COLD-PCR technology platform. This interim analysis demonstrates that in a high percentage of patients with advanced cancers, the same genetic mutations were detected in cell-free (cf) DNA present in the blood as were originally found in primary tumors. In addition, in a subset of patients who were followed over time, detection of mutations in cfDNA correlated with response to therapy or disease progression.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 28

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 161

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 78

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 342

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 86

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 24

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 207

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Mercy Medical Center Nurses Mobilize for Patient Safety Picket

Updated Category News Views 35

Nurses Standing Together for Patient Safety Nurses at Mercy Medical Center are uniting for a cause that affects them profoundly: the safety of their patients and the workplace. With issues surrounding unsafe staffing and deteriorating care conditions, nurses represented by the Massachusetts Nurses Association plan to hold an informational picket. This demonstration is not...

Continue Reading
Massive Merger: Qorvo and Skyworks Unite for Future Innovations

Updated Category News Views 306

Overview of the Strategic Merger In an exciting development in the technology sector, shares of Qorvo, Inc. (NASDAQ: QRVO) and Skyworks Solutions, Inc. (NASDAQ: SWKS) are experiencing a notable surge after announcing their intent to merge. This deal, which values the combined entity at approximately $22 billion, marks a significant step forward in the realm of...

Continue Reading
Oryzon Genomics Announces Corporate Updates for September

Updated Category News Views 178

Oryzon Genomics to Share Updates on Corporate Progress Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a leading clinical-stage biopharmaceutical company dedicated to epigenetic therapies for critical medical needs, is set to present its latest corporate updates at several major international events. These important gatherings scheduled for September will showcase...

Continue Reading
Envision Energy Launches Innovative Energy Storage Solution

Updated Category News Views 363

Introducing the EN 8 Pro: A Revolution in Energy Storage Envision Energy, a leader in sustainable technology, has made a significant breakthrough in energy management with the launch of its EN 8 Pro 8MWh DC Liquid-Cooled Energy Storage System. This innovative setup is set to establish new industry standards in safety, efficiency, and environmental adaptability. Designed...

Continue Reading
Beard Papa's Teams Up for Exciting Zenless Zone Zero Launch

Updated Category News Views 528

Beard Papa's Exciting Flavor Collaboration Begins Beard Papa's, renowned for its delectable cream puffs and irresistible custard fillings, is thrilled to announce a nationwide collaboration with Zenless Zone Zero. This partnership will launch an exciting in-game event that will allow fans to experience the unique flavors inspired by the action-RPG sensation from...

Continue Reading